WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it intends to build a new facility in Sherbrooke, Quebec, to support the company’s expanding Preclinical Services business. Located in the newly constructed Sherbrooke Biomedical Park, Charles River’s newest facility will provide essential drug discovery and development services to the international pharmaceutical and biopharmaceutical industries.
